Cargando…

Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations

The triglyceride-glucose (TyG) index has been identified as a reliable alternative biomarker of insulin resistance (IR). Recently, a considerable number of studies have provided robust statistical evidence suggesting that the TyG index is associated with the development and prognosis of cardiovascul...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Li-Chan, Xu, Jia-ni, Wang, Ting-ting, Hua, Fei, Li, Jian-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078015/
https://www.ncbi.nlm.nih.gov/pubmed/35524263
http://dx.doi.org/10.1186/s12933-022-01511-x
_version_ 1784702237312811008
author Tao, Li-Chan
Xu, Jia-ni
Wang, Ting-ting
Hua, Fei
Li, Jian-Jun
author_facet Tao, Li-Chan
Xu, Jia-ni
Wang, Ting-ting
Hua, Fei
Li, Jian-Jun
author_sort Tao, Li-Chan
collection PubMed
description The triglyceride-glucose (TyG) index has been identified as a reliable alternative biomarker of insulin resistance (IR). Recently, a considerable number of studies have provided robust statistical evidence suggesting that the TyG index is associated with the development and prognosis of cardiovascular disease (CVD). Nevertheless, the application of the TyG index as a marker of CVD has not systemically been evaluated, and even less information exists regarding the underlying mechanisms associated with CVD. To this end, in this review, we summarize the history of the use of the TyG index as a surrogate marker for IR. We aimed to highlight the application value of the TyG index for a variety of CVD types and to explore the potential limitations of using this index as a predictor for cardiovascular events to improve its application value for CVD and provide more extensive and precise supporting evidence.
format Online
Article
Text
id pubmed-9078015
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90780152022-05-08 Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations Tao, Li-Chan Xu, Jia-ni Wang, Ting-ting Hua, Fei Li, Jian-Jun Cardiovasc Diabetol Review The triglyceride-glucose (TyG) index has been identified as a reliable alternative biomarker of insulin resistance (IR). Recently, a considerable number of studies have provided robust statistical evidence suggesting that the TyG index is associated with the development and prognosis of cardiovascular disease (CVD). Nevertheless, the application of the TyG index as a marker of CVD has not systemically been evaluated, and even less information exists regarding the underlying mechanisms associated with CVD. To this end, in this review, we summarize the history of the use of the TyG index as a surrogate marker for IR. We aimed to highlight the application value of the TyG index for a variety of CVD types and to explore the potential limitations of using this index as a predictor for cardiovascular events to improve its application value for CVD and provide more extensive and precise supporting evidence. BioMed Central 2022-05-06 /pmc/articles/PMC9078015/ /pubmed/35524263 http://dx.doi.org/10.1186/s12933-022-01511-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Tao, Li-Chan
Xu, Jia-ni
Wang, Ting-ting
Hua, Fei
Li, Jian-Jun
Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations
title Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations
title_full Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations
title_fullStr Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations
title_full_unstemmed Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations
title_short Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations
title_sort triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078015/
https://www.ncbi.nlm.nih.gov/pubmed/35524263
http://dx.doi.org/10.1186/s12933-022-01511-x
work_keys_str_mv AT taolichan triglycerideglucoseindexasamarkerincardiovasculardiseaseslandscapeandlimitations
AT xujiani triglycerideglucoseindexasamarkerincardiovasculardiseaseslandscapeandlimitations
AT wangtingting triglycerideglucoseindexasamarkerincardiovasculardiseaseslandscapeandlimitations
AT huafei triglycerideglucoseindexasamarkerincardiovasculardiseaseslandscapeandlimitations
AT lijianjun triglycerideglucoseindexasamarkerincardiovasculardiseaseslandscapeandlimitations